Napoleon Waszkiewicz is an expert in Psychiatry at Medical University of Białystok (Poland). Napoleon Waszkiewicz has authored 275 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 913 (community average: 125). How the SLR is computed.

LeadR Profile

Napoleon Waszkiewicz Medical University of Białystok Poland
913 ScienceLeadR Reputation 913
Network Map

Psychiatry

Subspecialties: Biochemistry - Nutrition - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2008 - 2026

Source: PubMed

Medical University of Białystok

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 275

Citations

Citations: 4 029 1st author: 34 Last author: 113 Unique author: 7


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Artificial intelligence EEG biomarkers for schizophrenia diagnosis: Systematic review with PROBAST+AI assessment.
PMID 42878218 — intelligence, mental disorders, biomarkers, electroencephalography, schizophrenia, diagnosis, learning, artificial intelligence, psychiatry
Eur Psychiatry20260
The Inflamed Intestinal Barrier as a Formulation Variable in Oral Nanocarrier Design: Evidence-Informed Principles for Mucus Interaction, Epithelial Access, and Translational Testing.
PMID 42797307 — cells, research design, nanomedicine, inflammatory bowel diseases
Pharmaceutics20260
PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2 Study of Alofropodect (CPL'36) in Patients Experiencing Acute Schizophrenia.
PMID 42533223 — signs and symptoms, schizophrenia, therapeutics
CNS Drugs20260
Sex-dependent effects of psychedelics: review of evidence from rodent models.
PMID 42528876 — neuronal plasticity, psilocybin, hallucinogens, sex characteristics, sex, research, therapeutics, lysergic acid diethylamide, sex differences
Front Psychiatry20261
Esketamine in Treatment-Resistant Depression: Clinical and Translational Perspectives.
PMID 42515873 — depression, brain-derived neurotrophic factor, maintenance, therapeutics, depressive disorder, treatment-resistant, neuropharmacology
Curr Neuropharmacol20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1
Phase 2 1

By status:

Completed 2

By type:

Interventional 1
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map